4597 — Solasia Pharma KK Share News
0.000.00%
Table: Solasia Pharma -2022 group results (IFRS)
Table: Solasia Pharma -2022 group forecast(IFRS)
Table: Solasia Pharma -9-MTH group results (IFRS)
Table: Solasia Pharma -6-MTH group results (IFRS)
Brief: Camurus Divests Episil Oral Liquid Business To Solasia
Table: Solasia Pharma -Q1 group results (IFRS)
Table: Solasia Pharma -2021 parent results
Table: Solasia Pharma -2021 group results (IFRS)
Table: Solasia Pharma -9-MTH group results (IFRS)
Table: Solasia Pharma -2021 group forecast(IFRS)
Brief: Solasia, Nippon Kayaku Announce License Agreement In Japan For New Drug Candidate Darinaparsin
Table: Solasia Pharma -6-MTH group results (IFRS)
Table: Solasia Pharma -Q1 group results (IFRS)
Table: Solasia Pharma -2020 group results (IFRS)
Table: Solasia Pharma -2020 parent results
Table: Solasia Pharma -2020 group forecast(IFRS)
Table: Solasia Pharma -9-MTH group results (IFRS)
Table: Solasia Pharma -6-MTH group results (IFRS)
Table: Solasia Pharma -Q1 group results (IFRS)